Micronisation of carbamazepine through rapid expansion of supercritical solution (RESS)

被引:54
作者
Bolten, Dennis [1 ]
Tuerk, Michael [1 ]
机构
[1] KIT, Inst Tech Thermodynam & Refrigerat, D-76131 Karlsruhe, Germany
关键词
Carbamazepine; Dissolution behavior; Polymorphism; RESS; Supercritical CO2; ANHYDROUS POLYMORPHS; POLYMER PARTICLES; DISSOLUTION; DRUG; MICRONIZATION; FLUIDS; BIOAVAILABILITY; DISPERSION; CONVERSION; COMPOSITE;
D O I
10.1016/j.supflu.2011.06.014
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
A large number of pharmaceutical compounds are orally administered to the human body. If the drug shows a poor water-solubility and therewith low dissolution rate, a high dosage is needed which may cause undesired side effects to the human body. To improve the dissolution properties of these poorly water-soluble drugs, a large number of various strategies including micronisation, nano-emulsions and polymeric micelles are applied. In this paper we report on the formation of submicron carbamazepine particles by rapid expansion of supercritical solutions (RESS). The unprocessed and processed carbamazepine powder was characterized by means of scanning electron microscopy (SEM), X-ray diffraction (XRD), differential scanning calorimetry (DSC) and dissolution rate measurements. Due to the existence of four different polymorphic forms of carbamazepine, one focus is on the modification or change of the crystal structure of carbamazepine caused by RESS. The experimental results show that the particle size can be reduced at least by a factor of 29 to median sizes between 0.43 and 0.9 mu m and that pure C-monoclinic carbamazepine particles can be produced for pre-expansion temperatures >= 363 K. The dissolution rate of the product at pH 2 and 310 K could be enhanced in comparison to the unprocessed material. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:32 / 40
页数:9
相关论文
共 53 条
[1]  
[Anonymous], 2009, US PHARM USP 32
[2]  
[Anonymous], 1996, DTSCH ARZNEIBUCH MET
[3]  
Atkins P.W., 1987, PHYSIKALISCHE CHEM, P710
[4]   Production of micro- and nano-composite particles by supercritical carbon dioxide [J].
Bahrami, Masoud ;
Ranjbarian, Sima .
JOURNAL OF SUPERCRITICAL FLUIDS, 2007, 40 (02) :263-283
[5]   Interaction of pharmaceutical hydrates with supercritical CO2 -: Solubility, solid-state and chemical modifications [J].
Bettini, R ;
Bertolini, G ;
Frigo, E ;
Rossi, A ;
Casini, I ;
Pasquali, I ;
Giordano, F .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2004, 77 (02) :625-638
[6]   Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide [J].
Bettini, R ;
Bonassi, L ;
Castoro, V ;
Rossi, A ;
Zema, L ;
Gazzaniga, A ;
Giordano, F .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (03) :281-286
[7]   DEVELOPMENT OF AQUEOUS PARENTERAL FORMULATIONS FOR CARBAMAZEPINE THROUGH THE USE OF MODIFIED CYCLODEXTRINS [J].
BREWSTER, ME ;
ANDERSON, WR ;
ESTES, KS ;
BODOR, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (04) :380-383
[8]   Relative bioavailability estimation of carbamazepine crystal forms using an artificial stomach-duodenum model [J].
Carino, SR ;
Sperry, DC ;
Hawley, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 95 (01) :116-125
[9]   X-ray characterization of the triclinic polymorph of carbamazepine [J].
Ceolin, R ;
Toscani, S ;
Gardette, MF ;
Agafonov, VN ;
Dzyabchenko, AV ;
Bachet, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (09) :1062-1065
[10]   Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals [J].
Charoenchaitrakool, M ;
Dehghani, F ;
Foster, NR ;
Chan, HK .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2000, 39 (12) :4794-4802